Nancy Jean Cox to Influenza Vaccines
This is a "connection" page, showing publications Nancy Jean Cox has written about Influenza Vaccines.
Connection Strength
5.640
-
Global Influenza Surveillance and Response System: 70 years of responding to the expected and preparing for the unexpected. Lancet. 2022 09 24; 400(10357):981-982.
Score: 0.814
-
Seasonal influenza vaccines. Curr Top Microbiol Immunol. 2009; 333:43-82.
Score: 0.314
-
Inactivated and live attenuated influenza vaccines in young children--how do they compare? N Engl J Med. 2007 Feb 15; 356(7):729-31.
Score: 0.276
-
The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic. Proc Natl Acad Sci U S A. 2002 Aug 06; 99(16):10748-52.
Score: 0.201
-
Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA. 2000 Oct 04; 284(13):1677-82.
Score: 0.177
-
Influenza. Lancet. 1999 Oct 09; 354(9186):1277-82.
Score: 0.166
-
A ten-year China-US laboratory collaboration: improving response to influenza threats in China and the world, 2004-2014. BMC Public Health. 2019 May 10; 19(Suppl 3):520.
Score: 0.161
-
Kinetics of humoral response in children with acute lymphoblastic leukemia immunized with influenza vaccine in 1993 in Poland. Leuk Lymphoma. 1997 Jun; 26(1-2):163-9.
Score: 0.141
-
Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015. Vaccine. 2017 02 22; 35(8):1104-1109.
Score: 0.137
-
[Vaccination against influenza in children with acute lymphoblastic leukemia]. Pediatr Pol. 1996 Apr; 71(4):301-6.
Score: 0.130
-
Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs. Influenza Other Respir Viruses. 2015 Sep; 9(5):263-70.
Score: 0.125
-
Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs. PLoS One. 2015; 10(6):e0128982.
Score: 0.123
-
Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children. J Gen Virol. 1995 Jun; 76 ( Pt 6):1521-5.
Score: 0.123
-
Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine. 1995; 13(15):1399-402.
Score: 0.119
-
Estimated influenza illnesses and hospitalizations averted by vaccination--United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep. 2014 Dec 12; 63(49):1151-4.
Score: 0.119
-
Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model. Clin Vaccine Immunol. 2014 May; 21(5):722-31.
Score: 0.113
-
WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013. Vaccine. 2014 Aug 20; 32(37):4713-25.
Score: 0.112
-
Pandemic preparedness and the Influenza Risk Assessment Tool (IRAT). Curr Top Microbiol Immunol. 2014; 385:119-36.
Score: 0.111
-
Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis. 1993 Oct; 168(4):881-7.
Score: 0.109
-
WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011. Vaccine. 2012 Oct 05; 30(45):6461-71.
Score: 0.101
-
Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets. J Infect Dis. 2011 Nov 15; 204(10):1491-9.
Score: 0.095
-
Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2). Virology. 2011 Apr 10; 412(2):297-305.
Score: 0.091
-
The development of vaccine viruses against pandemic A(H1N1) influenza. Vaccine. 2011 Feb 17; 29(9):1836-43.
Score: 0.090
-
Exposure science for viral diseases: 2009 H1N1 pandemic influenza virus. J Expo Sci Environ Epidemiol. 2011 Jan-Feb; 21(1):1-2.
Score: 0.090
-
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010 Aug 06; 59(RR-8):1-62.
Score: 0.088
-
Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production. Influenza Other Respir Viruses. 2009 Nov; 3(6):287-95.
Score: 0.083
-
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009 Nov 12; 361(20):1945-52.
Score: 0.082
-
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009 Jul 31; 58(RR-8):1-52.
Score: 0.082
-
Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med. 2008 Dec 08; 168(22):2405-14.
Score: 0.078
-
Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome. J Infect Dis. 2008 Jul 15; 198(2):226-33.
Score: 0.076
-
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep. 2007 Jul 13; 56(RR-6):1-54.
Score: 0.071
-
Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis. 2006 Oct 15; 194(8):1032-9.
Score: 0.067
-
Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006 Jul 28; 55(RR-10):1-42.
Score: 0.066
-
Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Vaccine. 2006 Nov 17; 24(47-48):6859-66.
Score: 0.066
-
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2004 May 28; 53(RR-6):1-40.
Score: 0.057
-
Genetic stability of A/Ann Arbor/6/60 cold-mutant (temperature-sensitive) live influenza virus genes: analysis by oligonucleotide mapping of recombinant vaccine strains before and after replication in volunteers. J Infect Dis. 1984 Feb; 149(2):194-200.
Score: 0.056
-
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2003 Apr 25; 52(RR-8):1-34; quiz CE1-4.
Score: 0.053
-
Safety evaluation in chickens of candidate human vaccines against potential pandemic strains of influenza. Avian Dis. 2003; 47(3 Suppl):926-30.
Score: 0.052
-
Generation and characterization of an H9N2 cold-adapted reassortant as a vaccine candidate. Avian Dis. 2003; 47(3 Suppl):1127-30.
Score: 0.052
-
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2002 Apr 12; 51(RR-3):1-31.
Score: 0.049
-
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2001 Apr 20; 50(RR-4):1-44.
Score: 0.046
-
Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. Vaccine. 2000 Sep 15; 19(2-3):308-18.
Score: 0.044
-
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000 Apr 14; 49(RR-3):1-38; quiz CE1-7.
Score: 0.043
-
Prevention and control of influenza. Lancet. 1999 Dec; 354 Suppl:SIV30.
Score: 0.042
-
The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis. 1999 Sep-Oct; 5(5):659-71.
Score: 0.041
-
Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60. Virology. 1979 Aug; 97(1):190-4.
Score: 0.041
-
Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis. 1999 Mar; 28(3):541-7.
Score: 0.040
-
Influenza pandemic preparedness plan for the United States. J Infect Dis. 1997 Aug; 176 Suppl 1:S4-7.
Score: 0.036
-
Selection of antigenically advanced variants of seasonal influenza viruses. Nat Microbiol. 2016 05 23; 1(6):16058.
Score: 0.033
-
PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines. J Virol Methods. 1995 Mar; 52(1-2):41-9.
Score: 0.030
-
Nonimmunoselected intrastrain genetic variation detected in pairs of high-yielding influenza A (H3N2) vaccine and parental viruses. J Infect Dis. 1994 Dec; 170(6):1432-8.
Score: 0.030
-
Influenza activity - United States, 2013-14 season and composition of the 2014-15 influenza vaccines. MMWR Morb Mortal Wkly Rep. 2014 Jun 06; 63(22):483-90.
Score: 0.029
-
The global circulation of seasonal influenza A (H3N2) viruses. Science. 2008 Apr 18; 320(5874):340-6.
Score: 0.019
-
Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza virus: detection of mutations in all genes of the A/Ann Arbor/6/60 (H2N2) mutant vaccine donor strain. Microb Pathog. 1986 Aug; 1(4):387-97.
Score: 0.017
-
Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005 Dec 15; 353(24):2559-67.
Score: 0.016
-
A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol. 1999 Jul; 73(7):5903-11.
Score: 0.010
-
Meeting the challenge of emerging pathogens: the role of the United States Air Force in global influenza surveillance. Mil Med. 1997 Feb; 162(2):82-6.
Score: 0.009